Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15) Existence of optimal solutions belonging to restricted classes (Lipschitz controls, bang-bang controls, etc.) (49J30) Optimality conditions for problems involving ordinary differential equations (49K15) Optimality conditions for solutions belonging to restricted classes (Lipschitz controls, bang-bang controls, etc.) (49K30) Applications of optimal control and differential games (49N90) Application models in control theory (93C95)
- scientific article; zbMATH DE number 2062254
- Optimal control for a stochastic model of cancer chemotherapy
- Optimal control for cancer chemotherapy under tumor heterogeneity with Michealis-Menten pharmacodynamics
- scientific article; zbMATH DE number 3999722
- Optimal control of cancer treatments: mathematical models for the tumor microenvironment
- An optimal control problem in cancer chemotherapy
- Application of optimal control theory to analysis of cancer chemotherapy regimens
- Optimal control of cancer chemotherapy model using the coupled Adomian/Alienor methods
- Chemotherapy of a tumor by optimal control approach
- Optimal control for a mathematical model for chemotherapy with pharmacometrics
- scientific article; zbMATH DE number 3191476 (Why is no real title available?)
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Ensemble Control of Bloch Equations
- Geometric optimal control. Theory, methods and examples
- Introduction to the mathematical theory of control
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Singular controls and chattering arcs in optimal control problems arising in biomedicine
- Singular trajectories and their role in control theory
- The impact of cell density and mutations in a model of multidrug resistance in solid tumors
- The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models
- Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
- Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth
- The structure of optimal protocols for a mathematical model of chemotherapy with antiangiogenic effects
- Optimal control homotopy perturbation method for cancer model
- scientific article; zbMATH DE number 2062254 (Why is no real title available?)
- On the role of tumor heterogeneity for optimal cancer chemotherapy
- An operator theoretic approach to linear ensemble control
- Comparison of optimal controls for a model in cancer chemotherapy withL1- andL2-type objectives
- An adaptive pharmacokinetic optimal control approach in chemotherapy for heterogeneous tumor
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Finite-time fuzzy reliable controller design for fractional-order tumor system under chemotherapy
- Mathematical modeling and optimal control problems in brain tumor targeted drug delivery strategies
- On the optimal control of cancer radiotherapy for non-homogeneous cell populations
- Optimal control of cancer chemotherapy with delays and state constraints
- Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
- Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
- On applications of the Hamilton-Jacobi equations and optimal control theory to problems of chemotherapy of malignant tumors
- Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia
- Optimal control for cancer chemotherapy under tumor heterogeneity with Michealis-Menten pharmacodynamics
- Memory effects on the proliferative function in the cycle-specific of chemotherapy
- scientific article; zbMATH DE number 148942 (Why is no real title available?)
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy
- Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model
- Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model
- Combination of direct methods and homotopy in numerical optimal control: application to the optimization of chemotherapy in cancer
- Infinite horizon cancer treatment model with isoperimetrical constraint: existence of optimal solutions and numerical analysis
- Optimal chemotherapy schedules from tumor entropy
- Optimal control for a mathematical model for chemotherapy with pharmacometrics
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Bang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancer
- Chaos and optimal control of equilibrium states of tumor system with drug
- scientific article; zbMATH DE number 5150802 (Why is no real title available?)
- A survey of optimization models on cancer chemotherapy treatment planning
- Optimal Control on a Model for Cervical Cancer
- On optimal chemotherapy for heterogeneous tumors
- Optimal control in reducing side effects during and after chemotherapy of solid tumors
- A mathematical model of stroma-supported allometric tumor growth
This page was built for publication: Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q326554)